SCHEMBL4059151

SCHEMBL4059151

Cc1cc(Nc2nc(Nc3ccccc3S(C)(=O)=O)c3cn[nH]c3n2)c(OC(C)C)cc1C1CCNCC1

nearest known ligand 0.88

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALK Q9UM73 20/20 0.88
▸ INSR P06213 10/20 0.88
▸ NPM1 P06748 8/20 0.88
▸ KCNH2 Q12809 4/20 0.73
▸ CYP3A4 P08684 3/20 0.73
▸ PLK4 O00444 1/20 0.64
▸ BUB1B O60566 1/20 0.64
▸ JAK2 O60674 1/20 0.64
▸ ROCK2 O75116 1/20 0.64
▸ ABL1 P00519 1/20 0.64
▸ EGFR P00533 1/20 0.64
▸ NTRK1 P04629 1/20 0.64
▸ LCK P06239 1/20 0.64
▸ FES P07332 1/20 0.64
▸ LYN P07948 1/20 0.64
▸ RET P07949 1/20 0.64
▸ IGF1R P08069 1/20 0.64
▸ ABCB1 P08183 1/20 0.64
▸ MET P08581 1/20 0.64
▸ ROS1 P08922 1/20 0.64

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1069403 0.93 ALK (1.00) ALKINSRNPM1KCNH2CYP3A4
SCHEMBL4048849 0.91 ALK (0.88) ALKINSRNPM1KCNH2CYP3A4
SCHEMBL1546149 0.89 ALK (0.89) ALKINSRNPM1KCNH2CYP3A4
SCHEMBL18018794 0.86 ALK (0.68) ALKINSRNPM1KCNH2CYP3A4
SCHEMBL12245856 0.86 ALK (0.74) ALKINSRNPM1KCNH2CYP3A4
SCHEMBL12388844 0.85 ALK (0.84) ALKINSRNPM1KCNH2CYP3A4
SCHEMBL23637757 0.85 ALK (0.87) ALKINSRNPM1KCNH2PLK4
SCHEMBL14478221 0.85 ALK (0.84) ALKINSRNPM1KCNH2CYP3A4
SCHEMBL1545609 0.85 ALK (1.00) ALKINSRNPM1KCNH2CYP3A4
SCHEMBL29537500 0.85 ALK (1.00) ALKINSRNPM1KCNH2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009032703-A1 2- (HET) ARYLAMINO-6-AMINOPYRIDINE DERIVATIVES AND FUSED FORMS THEREOF AS ANAPLASTIC LYMPHOMA KINASE INHIBITORS IRM LLC (BM) 2009-03-12 — — WO claimed
WO-2009032694-A1 AMINO SUBSTITUTED PYRIMIDINE, PYROLLOPYRIDINE AND PYRAZOLOPYRIMIDINE DERIVATIVES USEFUL AS KINASE INHIBITORS AND IN TREATING PROLIFERATIVE DISORDERS AND DISEASES ASSOCIATED WITH ANGIOGENESIS DANA FARBER CANCER INSTITUTE (US) 2009-03-12 — — WO disclosed
WO-2009032703-A1 2- (HET) ARYLAMINO-6-AMINOPYRIDINE DERIVATIVES AND FUSED FORMS THEREOF AS ANAPLASTIC LYMPHOMA KINASE INHIBITORS IRM LLC (BM) 2009-03-12 — — WO disclosed
WO-2009032703-A1 2- (HET) ARYLAMINO-6-AMINOPYRIDINE DERIVATIVES AND FUSED FORMS THEREOF AS ANAPLASTIC LYMPHOMA KINASE INHIBITORS IRM LLC (BM) 2009-03-12 — — WO disclosed
Send feedback